Altimmune, Inc. - Common Stock — Cash Flow (NASDAQ:ALT) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -34.44 M-78.24 M-62.59 M-75.81 M-79.85 M-67.53 M -71.64 M Cash from investing activities -72.09 M87.52 M-73.4 M13.73 M-28.39 M-132.47 M -131.06 M Cash from financing activities 213.49 M65.1 M56.78 M86.11 M10.04 M206.84 M 251.2 M Free cash flow -34.44 M-78.24 M-62.59 M-75.81 M-79.85 M-67.55 M -71.66 M

News

Here's Why You Should Add Altimmune Stock to Your Portfolio Now

Altimmune's Q1 Loss Narrower Than Expected, Revenues Nil

Altimmune, Inc. (ALT) Q1 2026 Earnings Call Transcript

WAT Q1 Earnings Beat Estimates, BD Acquisition Aids Revenues

Altimmune Catalysts: 2026 Data Readouts and Financing Risks

ALT Stock: What Pemvidutide Means for MASH, AUD and ALD

Is Altimmune a Buy Before Phase III MASH Starts in 2026?

Altimmune: Why I'm Downgrading To Hold Despite MASH Promise (NASDAQ:ALT)

ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms

Altimmune Stock: Neutral Outlook With Big 2026 Catalysts

ALT Pemvidutide Explained: What Makes It Different in MASH

H.C. Wainwright raises Altimmune stock price target on MASH focus